Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma
Clinical trial NCT06552559 · RECRUITING
Trial details
- NCT number
- NCT06552559
- Sponsor
- Samsung Medical Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2028-12-30
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.